Symbols / SXTC
SXTC Chart
About
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 1.93M |
| Enterprise Value | -18.36M | Income | -8.87M | Sales | 1.54M |
| Book/sh | 26.16 | Cash/sh | 27.55 | Dividend Yield | — |
| Payout | 0.00% | Employees | 75 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 1.25 | P/B | 0.09 | P/C | — |
| EV/EBITDA | 2.20 | EV/Sales | -11.94 | Quick Ratio | 4.04 |
| Current Ratio | 4.37 | Debt/Eq | 5.95 | LT Debt/Eq | — |
| EPS (ttm) | -57.15 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -24.50% | Earnings | — | ROA | -18.27% |
| ROE | -50.30% | ROIC | — | Gross Margin | 21.74% |
| Oper. Margin | -10.12% | Profit Margin | 0.00% | Shs Outstand | 853.51K |
| Shs Float | 547.05K | Short Float | 5.74% | Short Ratio | 0.21 |
| Short Interest | — | 52W High | 1047.00 | 52W Low | 1.96 |
| Beta | 1.68 | Avg Volume | 283.42K | Volume | 27.90K |
| Target Price | — | Recom | None | Prev Close | $2.16 |
| Price | $2.26 | Change | 4.63% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.26
Latest analyst target
3. DCF / Fair value
$-41.09
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.26
Low
—
High
—
Mean
—
- Why one investor agreed to buy 66,666,666 shares of this drugmaker - Stock Titan Fri, 09 Jan 2026 08
- China SXT Pharmaceutics, Inc. Announces 1-for-150 Share Consolidation Effective February 3, 2026 - Quiver Quantitative Fri, 30 Jan 2026 08
- Why SXTC Shares Surge? - Nasdaq Mon, 02 Feb 2026 08
- China SXT Pharmaceuticals Inc (SXTC) - MSN hu, 19 Feb 2026 07
- Here’s Why China SXT Pharmaceuticals Stock (SXTC) Rocketed Today - TipRanks Mon, 02 Feb 2026 08
- Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) - Yahoo Finance ue, 13 Jan 2026 08
- This Nano-cap Pharma Stock Crashed 30% Today – What Triggered The Sell-off? - Stocktwits Fri, 30 Jan 2026 08
- What China SXT's 1-for-150 share consolidation means for holders - Stock Titan Fri, 30 Jan 2026 08
- Why Is Penny Stock China SXT (SXTC) Up Almost 200% Today? - TipRanks hu, 08 Jan 2026 08
- Top Chinese Stocks To Watch Now - January 27th - MarketBeat ue, 27 Jan 2026 08
- China SXT Pharmaceuticals to raise $10 million in share offering - Investing.com Fri, 09 Jan 2026 08
- SXTC Stock Soars Amid Strategic AI Initiative Expansion - timothysykes.com Fri, 09 Jan 2026 08
- China SXT Pharmaceuticals, Inc. Announces Share Consolidation - GlobeNewswire Fri, 30 Jan 2026 08
- China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering of Class A Ordinary Shares - Quiver Quantitative Fri, 09 Jan 2026 08
- China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering - Yahoo Finance Fri, 09 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.25 |
| NormalizedEBITDA | -2.57M | -2.35M | -5.21M | -5.05M |
| TotalUnusualItems | 0.00 | 0.00 | ||
| TotalUnusualItemsExcludingGoodwill | 0.00 | 0.00 | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -3.30M | -3.10M | -5.93M | -5.74M |
| ReconciledDepreciation | 82.30K | 203.25K | 250.16K | 320.01K |
| ReconciledCostOfRevenue | 1.37M | 1.37M | 1.55M | 1.35M |
| EBITDA | -2.57M | -2.35M | -5.21M | -5.05M |
| EBIT | -2.66M | -2.55M | -5.46M | -5.37M |
| NetInterestIncome | -648.22K | -544.28K | -476.78K | -36.70K |
| InterestExpense | 648.22K | 544.28K | 476.78K | 36.70K |
| NormalizedIncome | -3.30M | -3.10M | -5.93M | -5.74M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -3.30M | -3.10M | -5.93M | -5.74M |
| TotalExpenses | 4.42M | 4.44M | 7.58M | 7.79M |
| TotalOperatingIncomeAsReported | -2.68M | -2.52M | -5.61M | -5.19M |
| DilutedAverageShares | 9.49K | 1.85K | 381.00 | 67.00 |
| BasicAverageShares | 9.49K | 1.85K | 381.00 | 67.00 |
| DilutedEPS | -348.15 | -1.68K | -15.58K | -85.61K |
| BasicEPS | -348.15 | -1.68K | -15.58K | -85.61K |
| DilutedNIAvailtoComStockholders | -3.30M | -3.10M | -5.93M | -5.74M |
| NetIncomeCommonStockholders | -3.30M | -3.10M | -5.93M | -5.74M |
| NetIncome | -3.30M | -3.10M | -5.93M | -5.74M |
| NetIncomeIncludingNoncontrollingInterests | -3.30M | -3.10M | -5.93M | -5.74M |
| NetIncomeContinuousOperations | -3.30M | -3.10M | -5.93M | -5.74M |
| TaxProvision | 0.00 | 0.00 | 0.00 | 328.15K |
| PretaxIncome | -3.30M | -3.10M | -5.93M | -5.41M |
| OtherIncomeExpense | 25.05K | -39.04K | 149.51K | -181.58K |
| OtherNonOperatingIncomeExpenses | 25.05K | -39.04K | 149.51K | -181.58K |
| SpecialIncomeCharges | 0.00 | 0.00 | ||
| NetNonOperatingInterestIncomeExpense | -648.22K | -544.28K | -476.78K | -36.70K |
| TotalOtherFinanceCost | 476.78K | 36.70K | 1.62M | |
| InterestExpenseNonOperating | 648.22K | 544.28K | 476.78K | 36.70K |
| OperatingIncome | -2.68M | -2.52M | -5.61M | -5.19M |
| OperatingExpense | 3.05M | 3.07M | 6.03M | 6.44M |
| SellingGeneralAndAdministration | 3.05M | 3.07M | 6.03M | 6.44M |
| SellingAndMarketingExpense | 289.86K | 433.57K | 387.45K | 924.54K |
| GeneralAndAdministrativeExpense | 2.76M | 2.64M | 5.65M | 5.52M |
| OtherGandA | 2.76M | 2.64M | 5.65M | 5.52M |
| GrossProfit | 367.43K | 553.97K | 426.27K | 1.25M |
| CostOfRevenue | 1.37M | 1.37M | 1.55M | 1.35M |
| TotalRevenue | 1.74M | 1.93M | 1.97M | 2.60M |
| OperatingRevenue | 1.74M | 1.93M | 1.97M | 2.60M |
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 91.75K | 1.85K | 381.00 | 67.00 |
| ShareIssued | 91.75K | 1.85K | 381.00 | 67.00 |
| TotalDebt | 983.88K | 2.65M | 3.76M | 2.05M |
| TangibleBookValue | 15.43M | 13.91M | 14.66M | 16.39M |
| InvestedCapital | 16.25M | 16.34M | 18.14M | 18.47M |
| WorkingCapital | 15.28M | 5.33M | 5.02M | 5.33M |
| NetTangibleAssets | 15.43M | 13.91M | 14.66M | 16.39M |
| CapitalLeaseObligations | 176.65K | 235.85K | 306.05K | 0.00 |
| CommonStockEquity | 15.44M | 13.93M | 14.69M | 16.42M |
| TotalCapitalization | 15.54M | 14.05M | 14.81M | 16.42M |
| TotalEquityGrossMinorityInterest | 15.44M | 13.93M | 14.69M | 16.42M |
| StockholdersEquity | 15.44M | 13.93M | 14.69M | 16.42M |
| GainsLossesNotAffectingRetainedEarnings | -1.08M | -1.03M | -197.57K | 956.14K |
| OtherEquityAdjustments | -1.08M | -1.03M | -197.57K | 956.14K |
| RetainedEarnings | -28.02M | -24.71M | -21.61M | -15.69M |
| AdditionalPaidInCapital | 0.00 | 35.32M | 35.59M | 30.99M |
| CapitalStock | 44.53M | 4.35M | 913.78K | 162.47K |
| CommonStock | 44.53M | 4.35M | 913.78K | 162.47K |
| TotalLiabilitiesNetMinorityInterest | 6.22M | 9.20M | 14.86M | 17.12M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 211.68K | 294.67K | 365.82K | 0.00 |
| LongTermDebtAndCapitalLeaseObligation | 211.68K | 294.67K | 365.82K | 0.00 |
| LongTermCapitalLeaseObligation | 115.42K | 177.54K | 247.96K | 0.00 |
| LongTermDebt | 96.26K | 117.13K | 117.86K | 6.29K |
| CurrentLiabilities | 6.01M | 8.90M | 14.50M | 17.12M |
| OtherCurrentLiabilities | 674.39K | 361.54K | 789.23K | 1.16M |
| CurrentDeferredLiabilities | 58.63K | 187.66K | 165.53K | 77.37K |
| CurrentDeferredRevenue | 58.63K | 187.66K | 165.53K | 77.37K |
| CurrentDebtAndCapitalLeaseObligation | 772.19K | 2.35M | 3.39M | 2.05M |
| CurrentCapitalLeaseObligation | 61.23K | 58.31K | 58.09K | 0.00 |
| CurrentDebt | 710.97K | 2.29M | 3.33M | 2.05M |
| OtherCurrentBorrowings | 710.97K | 2.29M | 3.33M | 2.05M |
| CurrentProvisions | 53.88K | 213.57K | 111.95K | 122.77K |
| PayablesAndAccruedExpenses | 4.45M | 5.79M | 10.04M | 14.88M |
| CurrentAccruedExpenses | 1.10M | 1.23M | 949.59K | 846.97K |
| Payables | 3.35M | 4.56M | 9.09M | 14.03M |
| OtherPayable | 1.16M | 1.18M | 1.40M | 2.68M |
| DuetoRelatedPartiesCurrent | 0.00 | 1.05M | 5.20M | 8.70M |
| TotalTaxPayable | 1.03M | 1.05M | 1.10M | 1.17M |
| AccountsPayable | 1.16M | 1.28M | 1.38M | 1.48M |
| TotalAssets | 21.66M | 23.13M | 29.55M | 33.55M |
| TotalNonCurrentAssets | 367.02K | 8.89M | 10.03M | 11.09M |
| NonCurrentPrepaidAssets | 0.00 | 8.31M | 8.74M | 9.46M |
| NonCurrentDeferredAssets | 0.00 | 321.44K | ||
| NonCurrentDeferredTaxesAssets | 0.00 | 321.44K | ||
| GoodwillAndOtherIntangibleAssets | 11.81K | 19.10K | 27.87K | 38.76K |
| OtherIntangibleAssets | 11.81K | 19.10K | 27.87K | 38.76K |
| NetPPE | 355.21K | 564.69K | 1.27M | 1.59M |
| AccumulatedDepreciation | -2.59M | -2.53M | -1.98M | -1.82M |
| GrossPPE | 2.94M | 3.09M | 3.25M | 3.41M |
| Leases | 1.56M | 1.56M | 1.64M | 1.78M |
| ConstructionInProgress | 0.00 | 363.08K | 355.61K | |
| OtherProperties | 143.32K | 144.05K | 151.44K | 164.07K |
| MachineryFurnitureEquipment | 899.98K | 1.05M | 1.09M | 1.11M |
| BuildingsAndImprovements | 341.73K | 343.45K | 361.09K | 0.00 |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 21.30M | 14.23M | 19.52M | 22.45M |
| OtherCurrentAssets | 288.94K | 180.37K | ||
| CurrentDeferredAssets | 0.00 | 547.81K | ||
| RestrictedCash | 30.41K | 6.84K | 0.00 | 45.30K |
| PrepaidAssets | 438.85K | 14.90K | 46.30K | 50.31K |
| Inventory | 828.05K | 794.86K | 531.25K | 1.02M |
| InventoriesAdjustmentsAllowances | -56.41K | -79.55K | -158.83K | -172.07K |
| FinishedGoods | 448.67K | 553.68K | 446.87K | 584.75K |
| RawMaterials | 435.80K | 320.72K | 243.22K | 604.85K |
| Receivables | 1.90M | 1.35M | 1.58M | 5.81M |
| ReceivablesAdjustmentsAllowances | -466.53K | -468.88K | -473.24K | 0.00 |
| OtherReceivables | 523.07K | 500.51K | 645.50K | 849.13K |
| DuefromRelatedPartiesCurrent | 417.56K | 0.00 | 58.38K | 15.58K |
| AccruedInterestReceivable | 0.00 | 81.00K | 81.00K | |
| NotesReceivable | 0.00 | 35.51K | 0.00 | |
| LoansReceivable | 124.71K | 0.00 | 0.00 | 1.50M |
| AccountsReceivable | 1.30M | 1.31M | 1.34M | 3.33M |
| AllowanceForDoubtfulAccountsReceivable | -2.08M | -1.73M | -1.52M | -762.99K |
| GrossAccountsReceivable | 3.38M | 3.05M | 2.87M | 4.10M |
| CashCashEquivalentsAndShortTermInvestments | 18.10M | 12.07M | 17.37M | 15.52M |
| CashAndCashEquivalents | 18.10M | 12.07M | 17.37M | 15.52M |
| Line Item | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
| FreeCashFlow | -2.35M | -1.94M | -151.44K | 205.80K |
| RepaymentOfDebt | -1.92M | -78.65K | -26.11K | -33.05K |
| IssuanceOfDebt | 1.85M | 1.50M | 4.03M | 2.80M |
| IssuanceOfCapitalStock | 2.76M | 0.00 | 2.19M | 3.12M |
| CapitalExpenditure | -2.02K | -7.06K | -70.68K | -62.49K |
| InterestPaidSupplementalData | 21.24K | 24.53K | 13.05K | 3.20K |
| IncomeTaxPaidSupplementalData | 0.00 | 0.00 | 16.73K | 3.08K |
| EndCashPosition | 18.13M | 12.08M | 17.37M | 15.57M |
| BeginningCashPosition | 12.08M | 17.37M | 15.57M | 13.36M |
| EffectOfExchangeRateChanges | -65.09K | -765.23K | -1.05M | 394.12K |
| ChangesInCash | 6.12M | -4.53M | 2.85M | 1.82M |
| FinancingCashFlow | 8.40M | -2.62M | 2.94M | 1.60M |
| CashFlowFromContinuingFinancingActivities | 8.40M | -2.62M | 2.94M | 1.60M |
| NetOtherFinancingCharges | 5.70M | -4.04M | -3.26M | -4.26M |
| ProceedsFromStockOptionExercised | 0.00 | 0.00 | -30.00K | 0.00 |
| NetCommonStockIssuance | 2.76M | 0.00 | 2.19M | 3.12M |
| CommonStockIssuance | 2.76M | 0.00 | 2.19M | 3.12M |
| NetIssuancePaymentsOfDebt | -65.11K | 1.42M | 4.00M | 2.77M |
| NetShortTermDebtIssuance | 0.00 | 0.00 | -82.94K | |
| ShortTermDebtPayments | 0.00 | 0.00 | -82.94K | |
| ShortTermDebtIssuance | 3.72M | 2.80M | 0.00 | |
| NetLongTermDebtIssuance | -65.11K | 1.42M | 4.00M | 2.77M |
| LongTermDebtPayments | -1.92M | -78.65K | -26.11K | -33.05K |
| LongTermDebtIssuance | 1.85M | 1.50M | 4.03M | 2.80M |
| InvestingCashFlow | 63.52K | 26.42K | -12.30K | -46.91K |
| CashFlowFromContinuingInvestingActivities | 63.52K | 26.42K | -12.30K | -46.91K |
| NetOtherInvestingChanges | 33.49K | 58.38K | 15.58K | 3.13M |
| NetInvestmentPurchaseAndSale | 0.00 | 0.00 | -8.85M | |
| PurchaseOfInvestment | 0.00 | 0.00 | -8.85M | |
| NetIntangiblesPurchaseAndSale | 0.00 | 0.00 | ||
| PurchaseOfIntangibles | 0.00 | 0.00 | ||
| NetPPEPurchaseAndSale | 63.52K | -7.06K | -70.68K | -62.49K |
| SaleOfPPE | 65.54K | 0.00 | 0.00 | |
| PurchaseOfPPE | -2.02K | -7.06K | -70.68K | -62.49K |
| OperatingCashFlow | -2.35M | -1.93M | -80.76K | 268.29K |
| CashFlowFromContinuingOperatingActivities | -2.35M | -1.93M | -80.76K | 268.29K |
| ChangeInWorkingCapital | -971.74K | -381.56K | 1.42M | 1.90M |
| ChangeInOtherWorkingCapital | -128.81K | 30.44K | 94.34K | -186.40K |
| ChangeInOtherCurrentLiabilities | -228.84K | 38.06K | -74.41K | -360.86K |
| ChangeInPayablesAndAccruedExpense | 168.84K | -81.53K | -9.62K | 330.01K |
| ChangeInAccruedExpense | 298.76K | -53.84K | -46.37K | 384.80K |
| ChangeInPayable | -129.92K | -27.69K | 36.76K | -54.79K |
| ChangeInAccountPayable | -114.08K | -29.25K | 9.70K | -22.79K |
| ChangeInTaxPayable | -15.84K | 1.56K | 27.05K | -32.00K |
| ChangeInIncomeTaxPayable | -15.84K | 1.56K | 27.05K | -32.00K |
| ChangeInPrepaidAssets | -287.82K | 29.36K | 138.00 | 1.50M |
| ChangeInInventory | -14.53K | -219.65K | 408.95K | -180.80K |
| ChangeInReceivables | -480.56K | -178.25K | 996.11K | 796.40K |
| ChangesInAccountReceivables | -257.08K | -321.42K | 912.95K | 831.47K |
| OtherNonCashItems | 1.60M | 362.59K | 408.69K | 588.11K |
| StockBasedCompensation | 0.00 | 352.10K | 554.57K | 2.33M |
| ProvisionandWriteOffofAssets | 263.97K | 283.23K | 2.88M | 477.30K |
| AssetImpairmentCharge | -22.86K | 350.87K | 349.39K | 53.37K |
| DeferredTax | 0.00 | 0.00 | 328.15K | -192.68K |
| DeferredIncomeTax | 0.00 | 0.00 | 328.15K | -192.68K |
| DepreciationAmortizationDepletion | 82.30K | 203.25K | 250.16K | 320.01K |
| DepreciationAndAmortization | 82.30K | 203.25K | 250.16K | 320.01K |
| AmortizationCashFlow | 7.24K | 7.46K | ||
| AmortizationOfIntangibles | 7.24K | 7.46K | ||
| Depreciation | 75.06K | 195.79K | ||
| OperatingGainsLosses | 10.47K | 509.00K | ||
| GainLossOnInvestmentSecurities | 509.00K | |||
| GainLossOnSaleOfPPE | 10.47K | 0.00 | 0.00 | |
| NetIncomeFromContinuingOperations | -3.30M | -3.10M | -5.93M | -5.74M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for SXTC
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|